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ABSTRACT: Laser diffraction (LD) has been recognized as a method for estimating particle size distribution. Here, a recently developed
quantitative LD (qLD) system, which is an LD method with extensive deconvolution analysis, was employed for the quantitative assessment
of protein particles sizes, especially aimed at the quantification of 0.2–10 m diameter subvisible particles (SVPs). The qLD accurately
estimated concentration distributions for silica beads with diameters ranging from 0.2 to 10 m that have refractive indices similar to
that of protein particles. The linearity of concentration for micrometer-diameter silica beads was confirmed in the presence of a fixed
concentration of submicrometer diameter beads. Similarly, submicrometer-diameter silica beads could be quantified in the presence of
micrometer-diameter beads. Subsequently, stir- and heat-stressed intravenous immunoglobulins were evaluated by using the qLD, in which
the refractive index of protein particles that was determined experimentally was used in the deconvolution analysis. The results showed
that the concentration distributions of protein particles in SVP size range differ for the two stresses. The number concentration of the protein
particles estimated using the qLD agreed well with that obtained using flow microscopy. This work demonstrates that qLD can be used
for quantitative estimation of protein aggregates in SVP size range. C© 2014 The Authors. Journal of Pharmaceutical Sciences published by
Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:618–626, 2015
Keywords: laser diffraction method; proteins; protein aggregation; biopharmaceutical characterization; subvisible particles; imaging
methods; particle size
INTRODUCTION
Biopharmaceuticals such as antibody drugs have been success-
fully and widely used.1,2 In particular, the range of clinical ap-
plicability of antibody drugs for treating autoimmune diseases
and cancers has been expanded because of the high specificity
and low adverse effect of these drugs. A fraction of antibod-
ies is denatured during production, purification, and storage,
leading to the formation of protein aggregates. Recently, risk of
protein aggregates immunogenicity in vivo has been pointed
out; thus, proper monitoring and suppression of the aggre-
gates is expected. Assessment of protein aggregates has been
discussed,3,4 based on which the aggregates are divided into
four categories according to the particle size: diameters be-
low 0.2 :m (200 nm), from 0.2 to 2 :m, from 2 to 10 :m,
and from 10 to 25 :m.5 Quantitative assessment of protein
particles with diameters below 200 nm, or more strictly be-
low 100 nm, can be achieved by employing orthogonal meth-
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ods including size-exclusion chromatography (SEC), analyti-
cal ultracentrifugation (AUC),6,7 and field flow fractionation
(FFF). Protein particles with diameters in the 10–25 :m range
can be assessed by employing light obscuration (LO) or micro-
scopic observation. However, accurate quantification of protein
particles with diameters in the subvisible particle (SVP) size
range, especially in the 0.2–10 :m range, remains a challenge,
although flow microscopy technique is becoming a promising
method for quantitative assessment of protein particle sizes
in the 2–10 :m diameter range.8–10 FFF and Coulter counter
might be effective for evaluating submicron protein particle
diameters.11–14 Recently, nanoparticle tracking analysis (NTA)
and resonance mass measurement (RMM) were given signif-
icant attention for their potential use for assessing the pro-
tein particle sizes in the 0.2–2 :m diameter range. In NTA,
light scattered from individual particles in the object field is
continuously tracked to estimate translational diffusion coeffi-
cients of the particles from which their hydrodynamic diame-
ters are calculated using Stokes–Einstein equation, assuming
Brownian motion and ideally spherical particles.10,15 NTA al-
lows measuring particle diameters ranging from about 0.2–
1 :m; however, the technique is not suitable for assessing
mixtures of particles with broad distribution of sizes, because
estimating the signals from small particles becomes diffi-
cult because of intense light scattered from large particles.
RMM allows measuring particle diameters ranging from about
0.2–8 :m by using nanosensors, whereas particle diameters
ranging from about 0.2–2 :m can be measured using microsen-
sors when densities of water and protein particles are 1.00 and
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1.37 g/mL, respectively. In RMM, the buoyant mass of a parti-
cle is quantified; thus, the RMM is advantageous for discrimi-
nating particles with partial-specific volumes larger than that
of a solvent molecule from those with partial-specific volumes
smaller than that of a solvent molecule.16,17 In addition, none
of the above methods can provide concentration distributions
of protein particles in the whole 0.2–10 :m diameter range.
Laser diffraction (LD) method has been recognized as a method
for estimating the relative size distribution of particles. In the
present study, a recently developed quantitative LD system
(qLD), which is an LD method that uses extensive deconvolu-
tion analysis, was employed for simultaneously assessing the
concentration distributions of protein particles with diameters
in the 0.2–10 :m range.
MATERIALS AND METHODS
Materials
Silica Particles
Silica standard particles with diameters of 0.2 :m (200 nm),
0.5 :m (500 nm), and 1 :m were purchased from micromod
Partikeltechnologie GmbH (Rostock, Germany), whereas the
particles with diameters of 3 and 5 :m were purchased from
Polysciences, Inc. (Warrington, Pennsylvania). Diameters of sil-
ica standard particles were confirmed by the manufacturer by
using photon correlation spectroscopy for 0.2, 0.5, and 1 :m
diameter particles as 0.2 ± 0.02, 0.5 ± 0.05, and 1 ± 0.1 :m.
Values for 3 and 5 :m diameter particles were measured by
the manufacturer by using Coulter counter as 3.20 ± 0.37 and
5.06 ± 0.44 :m. The weight concentrations of these particles
were gravimetrically measured by the manufacturers. These
standard particles are not NIST traceable. The number con-
centrations of these silica particles were estimated from the
calculation that used the density of silica (2.0 g/cm3), the weight
concentrations of each silica particle solution, and the diame-
ters, as provided by the manufacturers.
Particles were diluted with water before use. Silica parti-
cles in sucrose aqueous solution with sucrose concentrations of
30%, 35%, 40%, 45%, 50%, 55%, and 60% (w/w) were prepared.
Sucrose was purchased from Wako Pure Chemical Industries,
Ltd. (Osaka, Japan).
Intravenous Immunoglobulin
For an intravenous immunoglobulin (IVIG) sample, Glovenin-I
for intravenous injection (250 units), a freeze-dried polyethy-
lene glycol-treated human immunoglobulin G, was purchased
from Nihon Pharmaceutical Company, Ltd. (Tokyo, Japan).
Glovenin-I was reconstituted by using the supplied solvent fol-
lowed by extensive dialysis against phosphate-buffered saline
(PBS; pH 7.4) with Slide-A-Lyzer G2 Dialysis Cassettes, 10K
MWCO, 3 mL (Thermo Scientific, Rockford, Illinois) to pre-
pare a stock solution. The stock solution of protein was stored
at 4◦C and adjusted to 0.87, 4.35, and 8.7 mg/mL by dilu-
tion with PBS (pH 7.4) before use. The protein concentrations
were determined using an extinction coefficient of 1.38 mL/mg
cm. Particles of protein aggregates were generated by stir and
heat stress. During the stir stress, 5 mL of the IVIG solution
(0.87 mg/mL) was set in a batch cell (Fig. 1b) and stirred by a
stirring blade (4.5× 29 mm2) for 8 h at 190 strokes/min at room
temperature. The prepared blade materials were glass, stain-
Figure 1. (a) Configuration and analysis flowchart for qLD instru-
ment and (b) schematic drawing of a batch cell with stirring blade.
less steel (SUS316), and polyethelethelketone (PEEK). During
the heat stress, 1 mL of the IVIG solution (0.87 mg/mL) in a
1.5-mL tube (Eppendorf Company, Ltd., Hamburg, Germany)
was heated for 5, 7, 9, and 15min at 70◦C in a heater (CHT-101;
SCINICS, Tokyo, Japan). The IVIG samples heated at 70◦C for
15 min were used to prepare sucrose PBS (50 mM phosphate
buffer, pH 7.4) solution with the sucrose concentrations, 40%,
45%, 50%, 55%, 60%, 65%, and 70% (w/w). Sucrose was pur-
chased from Wako Pure Chemical Industries, Ltd.
Methods
qLD Method
Particles in SVP size range were analyzed by employing the
qLD method using Aggregates Sizer (Shimadzu Corporation,
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Kyoto, Japan). Aggregates Sizer detects a scattered pattern,
which is the intensity of light scattered from particles at dif-
ferent angles, ranging from 0.04◦ to 160◦. The scattered pat-
tern from a spherical particle with a particular diameter and a
particular concentration in a solution can be theoretically ex-
pressed by using the quantitative optical model based on Mie
scattering theory; this approach requires knowing the real and
imaginary parts of refractive indices, for both the particles and
the medium (the solvent). The total amount of scattered light
from the particles is equal to the sum of the scattered light from
individual particles, assuming that multiple scattering can be
ignored in this range of concentrations. Thus, qLD provides
the concentration distribution of particles in solution through
deconvolution analysis of detected scattered pattern by using
a program that employs the quantitative optical model. On
the contrary, in conventional LD, the detected scattered pat-
tern is analyzed with a program that uses the optical model
in which the light intensity is normalized, resulting in relative
size distribution. Detailed description of Mie scattering theory
and deconvolution analysis is provided in Supporting Informa-
tion. The estimated concentration distribution is volume-based
distribution of particles. The volume concentration distribution
can be converted into the weight concentration distribution by
using the particles density. In addition, the volume concen-
tration distribution can be converted into the number concen-
tration distribution by using the equation for calculating the
volume of a spherical particle using the particle diameter.
Conventional LD methods give normalized particle size dis-
tribution; however, with qLD, it is possible to obtain the parti-
cle size distributionwith concentration information on particles
with defined sizes. The wavelength of the laser light of the qLD,
Aggregates Sizer, is 405 nm, allowing to effectively measure
submicron diameter particles with higher sensitivity and res-
olution. Samples were analyzed either in a cell with a volume
of 0.4 mL or in a cell with a volume of 5 mL, equipped with au-
tomatic stirring apparatus. A stirring blade made of stainless
steel (SUS316), glass, or PEEK was used in the present study.
The deconvolution analysis of acquired scattered patterns was
performed by using the WingSALD bio software (version 3.1.5)
provided by Shimadzu Corporation. The densities of 2.00 g/cm3
for silica beads and 1.37 g/cm3 for IVIG were used for convert-
ing the volume distribution into the weight distribution. The
qLD measurements by the Aggregates Sizer can be performed
by using both batch-type cell and flow-through-type cell.
Flow Microscopy
A number of particles with diameters above 1 :m were ana-
lyzed by using flow microscopy and employing DPA-4200 (Pro-
tein Simple, Santa Clara, California). The samples with their
volumes ranging from 0.0778 to 0.1698 mL were analyzed to
obtain the particle number concentrations.
Determination of Refractive Indices for Silica Beads and
Protein Particles
The scattered patterns from silica sucrose solution and IVIG
sucrose solution were analyzed to determine the real parts of
the corresponding refractive indices. For each concentration,
sucrose refractive indices were measured using a refractome-
ter (KPR-2000; Shimadzu Corporation) at the wavelength of
405 nm. The total scattered light intensity was calculated by
summing the intensity detected by the photodiode array, rang-
ing from 0.14◦ to 40◦, because the intensities in this range yield
the information on the SVPs with diameters ranging from 0.1
to 10 :m.
RESULTS AND DISCUSSION
Number and Weight Concentration Distributions for Silica
Beads Solution
Estimation of size distribution by LD requires the refractive
indices of particles for the wavelength used in the measure-
ment. A previous study reported that the refractive indices of
protein particles generated by stresses as 1.41.18 On the con-
trary, the refractive indices of silica beads were estimated as
1.42,18 which is close to those of the protein particles. It should
be noted that the deconvolution analysis employing Mie the-
ory requires the refractive indices of the particles and solvent
at the wavelength used for the data acquisition and that, im-
portantly, refractive index depends on the wavelength. In the
present study, the Aggregates Sizer was equipped with laser
light source at 405 nm. However, the above-mentioned reported
values were obtained for wavelengths other than 405 nm, and
were mostly refractive indices at 589 or 633 nm. In addition,
the outcome from deconvolution analysis of scattered pattern
in qLD is largely affected by the refractive indices of particle
and solvent; thus, to infer the possibility of using the qLD for
the quantitative assessment of protein particles, it is important
to know whether the concentration distribution of silica beads
can be properly quantified by using the qLD with appropriate
refractive indices. So far, the refractive indices of neither sil-
ica beads nor protein particles have been reported at 405 nm;
thus, we first measured the refractive indices at 405 nm of sil-
ica beads with different diameters. Figure 2a shows the total
scattered light intensity detected by the Aggregates Sizer for
silica sucrose solutions. The total intensity became minimal at
the refractive index of 1.43, regardless of the silica beads di-
ameter. This result is close to the value reported previously18
and suggests that the real part of the refractive index of silica
beads at 405 nm could be taken as 1.43. Then, the concentration
distributions of silica beads were estimated by using the qLD,
which was archived by the deconvolution analysis of scattered
patterns acquired by the Aggregates Sizer, with the real and
imaginary parts of the refractive index of silica beads estimated
as 1.43 and 0, respectively, and the real and imaginary parts
of the refractive index of the solvent estimated as 1.33 and 0,
respectively. As shown in Figure 2b, for particle diameters be-
low 3 :m, as the diameter of the silica beads become larger,
the peak position of the scattered light shifts from the larger
numbered detector to the smaller numbered detector, imply-
ing that the scattering pattern changes from higher scattering
weighted one to lower scattering weighted one. In the patterns
obtained for 3 and 5 :m diameter particles, diffraction from the
particles was apparently confirmed at the higher numbered
detector in addition to the scattered light at the lower num-
bered detector. Figure 2c (weight-based) and Supplementary
Figure S1A (number-based) show the distribution estimates of
silica beads, calculated from the deconvolution analysis of the
scattered pattern, and the mean diameters of the particles are
presented in Figure 2d and Supplementary Figure S1B. The
mean diameter was consistent with the diameter provided by
the manufacturer in a wide range of concentrations. Figure 2e
and Supplementary Figure S1C show the weight and number
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Figure 2. (a) Scattered light intensity of silica particles in sucrose solutions with different refractive indices. Error bars represent standard
deviations from triplicate samples. Solutions were prepared in triplicates. (b) Representative scattered light intensity distribution and (c) particle
size distribution of silica particles, obtained using the qLD. (d) Mean size of silica particles, for different particle concentrations, estimated using
the qLD. (e) Expected weight concentrations versus weight concentrations obtained using the qLD method, for silica particles. (f) Representative
particle size distributions for silica mixture particles estimated using the qLD. (g) Expected weight concentrations versus weight concentrations
obtained using the qLD method, for silica particles mixtures. Silica particles of 0.5 and 3 :m diameters were mixed. Concentration of particles
with a diameter was fixed at 150 :g/mL, whereas that of particles with another diameter was changed.
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concentration estimates for each sample, respectively. The
weight concentration estimates showed a linear relationship
with the concentration calculated according to the value pro-
vided by the manufacturer. The measurement errors of weight
concentration were below 30%, except for the 5-:m diameter
particles in low-concentration condition. On the contrary, the
estimated number concentrations (Supplementary Fig. S1C)
of particles with diameters above 1 :m in high-concentration
conditions significantly exceeded the expected values. This dis-
crepancy from the expected values is possibly caused by mul-
tiple scattering that occurred in high-concentration conditions.
These results indicate that the qLD allows correct quantifying
of particle sizes and concentrations of subvisible range particles
with diameters ranging from 0.2 to 10 :m, within the appro-
priate range of concentrations. Subsequently, mixture solutions
composed of different-size silica beads were evaluated by using
the qLD. Figure 2f and Supplementary Figure S1D show the
concentration distribution estimates for the mixture of sub-
micrometer and micrometer diameter silica beads. Figure 2g
and Supplementary Figure S1E show the weight and number
concentration estimates, respectively, of 0.5 :m diameter silica
beads (circle) and of 3 :m diameter silica beads (square) in the
mixture. Results show that weight and number concentration
estimates of 0.5 :m diameter silica beads under a fixed concen-
tration of coexisting 3 :m diameter silica beads exhibit linear
correlation with the corresponding concentration calculated ac-
cording to the value provided by the manufacturer. The linear
correlation was also confirmed for different weight and num-
ber concentration estimates of 3 :m diameter silica beads in
the presence of a fixed concentration of 0.5 :m diameter silica
beads.
Size Distribution with Concentration Information for IVIG
Aggregates Solution
To determine the refractive indices of protein particles, the scat-
tered pattern for sucrose solution containing heat- or shake-
stressed IVIG was measured by using the Aggregates Sizer. As
shown in Figure 3, scattered light intensities of both stressed
samples attained minima at the refractive index of 1.46. Zolls
et al.18 had previously reported that the refractive index of pro-
tein particles is 1.41 for heat-stressed HSA aggregates and for
stir-stressed IgG aggregates. Recall that the refractive index
Figure 3. Scattered light intensity of the IVIG aggregates in sucrose
solutions with different refractive indices. IVIG aggregates generated
by heat or shake stress were tested.
Figure 4. (a) Scattered light intensity distribution and (b) particle
size distribution of the IVIG heat stressed at 70◦C.
depends on the wavelength used for the measurement and that
the Aggregates Sizer uses a laser beam at 405 nm, whereas the
reported values are for 589 nm. Thus, in the present study, we
used the experimentally determined refractive index of IVIG
aggregates, 1.46 and 0.1 for the real and imaginary parts of the
IVIG sample’s refractive index, respectively. Figure 4a shows
the scattered intensity, whereas the distribution estimates for
heat-stressed IVIG sample are shown in Figure 4b (for weight
concentration) and Supplementary Figure S2 (for number
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Figure 5. (a) Scattered light intensity distribution and (b) particle size distribution of the IVIG under stir stress in the batch cell with glass-
made stirring blade. (c) Temporal dependence of concentration for the IVIG aggregates induced by stir stress in the batch cell with glass-made
stirring blade. (d) Temporal dependence of concentration for the IVIG aggregates induced by stir stress in the batch cell with glass, PEEK,
or SUS316-made stirring blade. Temporal results (c and d) were obtained from the deconvolution analysis of data taken by real-time qLD
measurements.
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concentration). Obviously, as illustrated in Figure 4a, increas-
ing maximal scattered light intensity without any change in
the apparent intensity profile shape was observed for longer
heating duration, which corresponds to increasing particles
concentration with increased heating duration. The scattered
intensity patterns that were stronger at higher numbered de-
tectors imply stronger presence of smaller diameter particles.
In fact, the deconvolution analysis clearly yielded particles con-
centration increase at around the diameter of 0.2 :m, whereas
weaker presence of particles with diameters above 1 :m was
confirmed even when the heating duration increased (Fig. 4b;
Supplementary Fig. S2). However, a stir-stressed IVIG sample
exhibited different distributions, namely, scattered light inten-
sity increased as the stirring time increased (Fig. 5a), whereas
concentration distribution was apparently unchanged (Fig. 5b;
Supplementary Fig. S3A). Regarding the particle formation
by stir stress, the time-dependent weight concentration esti-
mates obtained when the IVIG solution was stirred by using
glass-made stirring blade are shown in Figure 5c and Supple-
mentary Fig. S3B, and it is seen that the particle concentra-
tions for different size range particles linearly increased with
time. Notably, smaller size particles exhibited stronger increase
in the corresponding number concentration (Supplementary
Fig. S3B), whereas for the particles with diameters ranging
from 1 to 5 :m, the weight concentration exhibited the fastest
growth. Size distributions of protein particles induced by heat,
shake, and stir stress were previously investigated. Hawe
et al.19 reported a significant increase of particle number in
submicrometer diameter range when the protein solution was
heated. In fact, assuming that the density of protein aggre-
gates is 1.37 g/cm3, the amount of heat-induced aggregates in
micrometer diameter range calculated based on the number
and size of aggregates counted by LO was less than 1% of to-
tal amount, whereas the amount of small aggregates, typically
those with diameters below 100 nm, estimated from SEC, ex-
ceeded 10%. Filipe et al.20 also showed that heat-induced ag-
gregates have diameters of around 200 nm. On the contrary,
stirring-induced aggregates had diameters in the micrometer
range,21,22 ranging from 1 to 5 :m and from 2 to 10 :m. In the
present study, we demonstrated that the results were consis-
tent with the results of the previous studies, in that the dom-
inant increase of particle number in the submicrometer range
diameter was obtained for heat-induced aggregates, whereas
for the micrometer range diameter, the dominant increase was
obtained for stirring-induced aggregates. The rate of the weight
concentration increase obtained by using the glass-made stir-
ring blade was faster than those achieved by using stainless
steel or PEEK-made stirring blades (Fig. 5d; Supplementary
Fig. S3C). It was pointed out that proteins tend to adsorb to
form layers of films on the glass surface and the films are rup-
tured into solution,23 constituting the major source of particles.
The current result shows that the qLD can be utilized for the
assessment of materials for stirring during protein production
and purification. To confirm the concentration estimated by us-
ing the qLD method, the number concentration estimate by
the qLD for IVIG heated at 70◦C for 15 min was compared
with that obtained by using flow microscopy. The result clearly
demonstrated a good correspondence between the number con-
centration estimates obtained by using the qLD and flow mi-
croscopy, for particle diameters ranging from 1 to 5 :m (Fig. 6).
The potential error of flow microscopy originated from the vol-
umeused in this study is 20%according to the previous report.24
Figure 6. Number concentrations of the IVIG aggregates generated
by heat stress at 70◦C for 15 min, estimated using the qLD and flow
microscopy. Error bars represent standard deviations from triplicate
measurements.
Actual protein solution could contain particles other than pro-
teins, such as silicone oil, glass, and metals. According to the
report of Barnard et al.,25 the maximal concentration of sili-
cone oil particles derived from the container is 2.3 × 106 parti-
cles/mL for particle diameters ranging from 0.4 to 2 :m. Thus,
we performed simulations to estimate the influence of silicone
oil particles in the solution on the scattered light pattern ob-
tained by using the qLD. Assuming that the refractive index
and the concentration of silicone oil particles were 1.41 and
2.3 × 106 particles/mL, respectively, we calculated the scat-
tered light from silicone oil particles with diameters of 0.4, 1,
and 2 :m. As a result, the total scattered light intensities for
the 0.4-:m and the 1-:m diameter particles were below the
detection limit, whereas that for the 2-:m diameter particles
significantly affected the scattered light pattern.
Impact of Refractive Index on qLD Analysis
In the present study, we experimentally determined refractive
indices of both silica beads and protein particles at 405 nm, and
used them for the deconvolution analysis of the scattered pat-
tern. We tested how a change in the refractive index affects the
qLD results. As indicated in Supplementary Figure S4, when
the real part of the refractive index of protein particles was
changed from 1.46 to 1.44 or 1.48, corresponding to only 1.4%
change of the value, the number concentration of particles in
the 0.2–2-:m diameter range changed by 23% for 1.44 and by
18% for 1.48, whereas the number concentration of particles in
the 2–10-:m diameter range changed by approximately 12.4%
for 1.44 and by 2% for 1.48. These results indicate that the ef-
fect of refractive index on the number of particles is stronger
in the 0.2–2-:m diameter range compared with the 2–10-:m
diameter range. These results demonstrate the importance of
direct measurement of refractive indices for particles and sol-
vents (medium) comprising a solution in qLD analysis.
Comparison of qLD with Other Methods
The comparison of qLD with other methods used for SVP as-
sessment is summarized in Table 1. It is obvious that qLD
allows quantitative estimation of particle size distributions in
a wide range of particle sizes.
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Table 1. Comparison Table of qLD and Other Methods
Method
Instrument
(Manufacturer) Size Range Quantification
Concentration Range
(Particles/mL)
Monitoring Under
Stress Condition
Flow microscopy MFI5200
(ProteinSimple)
1–70 :m Yes Up to 9 × 105 (@ 2.5 :m) No
Light obscuration System 9703+
(Beckman)
1.2–150 :m Yes Up to 1.8 × 104 No
Resonant mass
measurement
Archimedes (Affinity
Biosensors)
0.05–5 :m Yes 104–109 No
Nanoparticle
tracing analysis
NS500 (NanoSight) 0.03–1 :m Yes 106–109 No
Dynamic light
scattering
ZetasizerNano ZS
(Malvern)
0.0003–10 :m No – No
Laser diffraction SALD-7500nano
(Shimadzu)
0.007–800 :m No – No
Quantitative laser
diffraction
Aggregates Sizer
(Shimadzu)
0.04–20 :m Yes 107–109 (@ 0.5 :m)
105–107 (@ 3 :m)
Yes (stir stress)
CONCLUSION
We have successfully developed a qLD method that employs
extensive deconvolution analysis of scattered light pattern de-
tected in a wide range of scattered angles. With the experimen-
tally determined refractive indices of silica beads or protein par-
ticles, we were able to correctly estimate the number and size of
silica beads by using the qLD even when particles of different
diameters coexisted in the solution, and the protein particles
generated by heat stress and stir stress could also be quantified
by using the proposed qLD. Batch cell with continuous stirring
blade provided the temporal dependence of protein particle for-
mation, from which a clue regarding the kinetic understanding
of the protein aggregates formation could be obtained. Most
importantly, the developed qLD allows simultaneously analyz-
ing the particles with diameters ranging from 0.2 to 10 :m;
thus, the proposed method is expected to be highly useful for
the quantitative evaluation of protein aggregates in subvisible
size range.
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